Global Mebendazole Market Growth 2021-2026

  • receipt Report ID : 255244
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 130
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Mebendazole will have significant change from previous year. By the most conservative estimates of global Mebendazole market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 108.9 million in 2020. Over the next five years the Mebendazole market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 136.5 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Mebendazole market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Tablet

Oral Suspension

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Below 2 Years Old

Above 2 Years Old

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Johnson & Johnson

Amneal Pharmaceuticals

Cadila Pharmaceuticals

Eipico

Esteve Pharmaceuticals

Tenry

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Mebendazole Consumption 2016-2026

2.1.2 Mebendazole Consumption CAGR by Region

2.2 Mebendazole Segment by Type

2.2.1 Tablet

2.2.2 Oral Suspension

2.3 Mebendazole Sales by Type

2.3.1 Global Mebendazole Sales Market Share by Type (2016-2021)

2.3.2 Global Mebendazole Revenue and Market Share by Type (2016-2021)

2.3.3 Global Mebendazole Sale Price by Type (2016-2021)

2.4 Mebendazole Segment by Application

2.4.1 Below 2 Years Old

2.4.2 Above 2 Years Old

2.5 Mebendazole Sales by Application

2.5.1 Global Mebendazole Sale Market Share by Application (2016-2021)

2.5.2 Global Mebendazole Revenue and Market Share by Application (2016-2021)

2.5.3 Global Mebendazole Sale Price by Application (2016-2021)

3 Global Mebendazole by Company

3.1 Global Mebendazole Sales Market Share by Company

3.1.1 Global Mebendazole Sales by Company (2019-2021)

3.1.2 Global Mebendazole Sales Market Share by Company (2019-2021)

3.2 Global Mebendazole Revenue Market Share by Company

3.2.1 Global Mebendazole Revenue by Company (2019-2021)

3.2.2 Global Mebendazole Revenue Market Share by Company (2019-2021)

3.3 Global Mebendazole Sale Price by Company

3.4 Global Manufacturers Mebendazole Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Mebendazole Product Location Distribution

3.4.2 Players Mebendazole Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Mebendazole by Region

4.1 Global Mebendazole by Region

4.1.1 Global Mebendazole Sales by Region

4.1.2 Global Mebendazole Revenue by Region

4.2 Americas Mebendazole Sales Growth

4.3 APAC Mebendazole Sales Growth

4.4 Europe Mebendazole Sales Growth

4.5 Middle East & Africa Mebendazole Sales Growth

5 Americas

5.1 Americas Mebendazole Sales by Country

5.1.1 Americas Mebendazole Sales by Country (2016-2021)

5.1.2 Americas Mebendazole Revenue by Country (2016-2021)

5.2 Americas Mebendazole Sales by Type

5.3 Americas Mebendazole Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Mebendazole Sales by Region

6.1.1 APAC Mebendazole Sales by Region (2016-2021)

6.1.2 APAC Mebendazole Revenue by Region (2016-2021)

6.2 APAC Mebendazole Sales by Type

6.3 APAC Mebendazole Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Mebendazole by Country

7.1.1 Europe Mebendazole Sales by Country (2016-2021)

7.1.2 Europe Mebendazole Revenue by Country (2016-2021)

7.2 Europe Mebendazole Sales by Type

7.3 Europe Mebendazole Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Mebendazole by Country

8.1.1 Middle East & Africa Mebendazole Sales by Country (2016-2021)

8.1.2 Middle East & Africa Mebendazole Revenue by Country (2016-2021)

8.2 Middle East & Africa Mebendazole Sales by Type

8.3 Middle East & Africa Mebendazole Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Mebendazole Distributors

10.3 Mebendazole Customer

11 Global Mebendazole Market Forecast

11.1 Global Mebendazole Forecast by Region

11.1.1 Global Mebendazole Forecast by Regions (2021-2026)

11.2.2 Global Mebendazole Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Mebendazole Forecast by Type

11.7 Global Mebendazole Forecast by Application

12 Key Players Analysis

12.1 Johnson & Johnson

12.1.1 Johnson & Johnson Company Information

12.1.2 Johnson & Johnson Mebendazole Product Offered

12.1.3 Johnson & Johnson Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Johnson & Johnson Main Business Overview

12.1.5 Johnson & Johnson Latest Developments

12.2 Amneal Pharmaceuticals

12.2.1 Amneal Pharmaceuticals Company Information

12.2.2 Amneal Pharmaceuticals Mebendazole Product Offered

12.2.3 Amneal Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Amneal Pharmaceuticals Main Business Overview

12.2.5 Amneal Pharmaceuticals Latest Developments

12.3 Cadila Pharmaceuticals

12.3.1 Cadila Pharmaceuticals Company Information

12.3.2 Cadila Pharmaceuticals Mebendazole Product Offered

12.3.3 Cadila Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Cadila Pharmaceuticals Main Business Overview

12.3.5 Cadila Pharmaceuticals Latest Developments

12.4 Eipico

12.4.1 Eipico Company Information

12.4.2 Eipico Mebendazole Product Offered

12.4.3 Eipico Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Eipico Main Business Overview

12.4.5 Eipico Latest Developments

12.5 Esteve Pharmaceuticals

12.5.1 Esteve Pharmaceuticals Company Information

12.5.2 Esteve Pharmaceuticals Mebendazole Product Offered

12.5.3 Esteve Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Esteve Pharmaceuticals Main Business Overview

12.5.5 Esteve Pharmaceuticals Latest Developments

12.6 Tenry

12.6.1 Tenry Company Information

12.6.2 Tenry Mebendazole Product Offered

12.6.3 Tenry Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Tenry Main Business Overview

12.6.5 Tenry Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Mebendazole Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Tablet

Table 3. Major Players of Oral Suspension

Table 4. Global Mebendazole Sales by Type (2016-2021) & (K Units)

Table 5. Global Mebendazole Sales Market Share by Type (2016-2021)

Table 6. Global Mebendazole Revenue by Type (2016-2021) & ($ million)

Table 7. Global Mebendazole Revenue Market Share by Type (2016-2021)

Table 8. Global Mebendazole Sale Price by Type (2016-2021)

Table 9. Global Mebendazole Sales by Application (2016-2021) & (K Units)

Table 10. Global Mebendazole Sales Market Share by Application (2016-2021)

Table 11. Global Mebendazole Value by Application (2016-2021)

Table 12. Global Mebendazole Revenue Market Share by Application (2016-2021)

Table 13. Global Mebendazole Sale Price by Application (2016-2021)

Table 14. Global Mebendazole Sales by Company (2019-2021) & (K Units)

Table 15. Global Mebendazole Sales Market Share by Company (2019-2021)

Table 16. Global Mebendazole Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Mebendazole Revenue Market Share by Company (2019-2021)

Table 18. Global Mebendazole Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Mebendazole Producing Area Distribution and Sales Area

Table 20. Players Mebendazole Products Offered

Table 21. Mebendazole Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Mebendazole Sales by Region (2016-2021) (K Units)

Table 25. Global Mebendazole Sales Market Share by Region (2016-2021)

Table 26. Global Mebendazole Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Mebendazole Revenue Market Share by Region (2016-2021)

Table 28. Americas Mebendazole Sales by Country (2016-2021) & (K Units)

Table 29. Americas Mebendazole Sales Market Share by Country (2016-2021)

Table 30. Americas Mebendazole Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Mebendazole Revenue Market Share by Country (2016-2021)

Table 32. Americas Mebendazole Sales by Type (2016-2021) & (K Units)

Table 33. Americas Mebendazole Sales Market Share by Type (2016-2021)

Table 34. Americas Mebendazole Sales by Application (2016-2021) & (K Units)

Table 35. Americas Mebendazole Sales Market Share by Application (2016-2021)

Table 36. APAC Mebendazole Sales by Region (2016-2021) & (K Units)

Table 37. APAC Mebendazole Sales Market Share by Region (2016-2021)

Table 38. APAC Mebendazole Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Mebendazole Revenue Market Share by Region (2016-2021)

Table 40. APAC Mebendazole Sales by Type (2016-2021) & (K Units)

Table 41. APAC Mebendazole Sales Market Share by Type (2016-2021)

Table 42. APAC Mebendazole Sales by Application (2016-2021) & (K Units)

Table 43. APAC Mebendazole Sales Market Share by Application (2016-2021)

Table 44. Europe Mebendazole Sales by Country (2016-2021) & (K Units)

Table 45. Europe Mebendazole Sales Market Share by Country (2016-2021)

Table 46. Europe Mebendazole Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Mebendazole Revenue Market Share by Country (2016-2021)

Table 48. Europe Mebendazole Sales by Type (2016-2021) & (K Units)

Table 49. Europe Mebendazole Sales Market Share by Type (2016-2021)

Table 50. Europe Mebendazole Sales by Application (2016-2021) & (K Units)

Table 51. Europe Mebendazole Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Mebendazole Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Mebendazole Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Mebendazole Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Mebendazole Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Mebendazole Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Mebendazole Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Mebendazole Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Mebendazole Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Mebendazole

Table 61. Key Application and Potential Industries of Mebendazole

Table 62. Key Challenges of Mebendazole

Table 63. Key Trends of Mebendazole

Table 64. Mebendazole Distributors List

Table 65. Mebendazole Customer List

Table 66. Global Mebendazole Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Mebendazole Consumption Market Forecast by Region

Table 68. Global Mebendazole Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Mebendazole Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Mebendazole Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Mebendazole Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Mebendazole Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Mebendazole Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Mebendazole Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Mebendazole Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Mebendazole Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Mebendazole Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Mebendazole Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Mebendazole Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Mebendazole Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Mebendazole Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Mebendazole Revenue Market Share Forecast by Application (2021-2026)

Table 86. Johnson & Johnson Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors

Table 87. Johnson & Johnson Mebendazole Product Offered

Table 88. Johnson & Johnson Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 89. Johnson & Johnson Main Business

Table 90. Johnson & Johnson Latest Developments

Table 91. Amneal Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors

Table 92. Amneal Pharmaceuticals Mebendazole Product Offered

Table 93. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 94. Amneal Pharmaceuticals Main Business

Table 95. Amneal Pharmaceuticals Latest Developments

Table 96. Cadila Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors

Table 97. Cadila Pharmaceuticals Mebendazole Product Offered

Table 98. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 99. Cadila Pharmaceuticals Main Business

Table 100. Cadila Pharmaceuticals Latest Developments

Table 101. Eipico Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors

Table 102. Eipico Mebendazole Product Offered

Table 103. Eipico Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 104. Eipico Main Business

Table 105. Eipico Latest Developments

Table 106. Esteve Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors

Table 107. Esteve Pharmaceuticals Mebendazole Product Offered

Table 108. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 109. Esteve Pharmaceuticals Main Business

Table 110. Esteve Pharmaceuticals Latest Developments

Table 111. Tenry Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors

Table 112. Tenry Mebendazole Product Offered

Table 113. Tenry Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 114. Tenry Main Business

Table 115. Tenry Latest Developments

List of Figures

Figure 1. Picture of Mebendazole

Figure 2. Mebendazole Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Mebendazole Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Mebendazole Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Mebendazole Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Tablet

Figure 10. Product Picture of Oral Suspension

Figure 11. Global Mebendazole Sales Market Share by Type in 2020

Figure 12. Global Mebendazole Revenue Market Share by Type (2016-2021)

Figure 13. Mebendazole Consumed in Below 2 Years Old

Figure 14. Global Mebendazole Market: Below 2 Years Old (2016-2021) & (K Units)

Figure 15. Mebendazole Consumed in Above 2 Years Old

Figure 16. Global Mebendazole Market: Above 2 Years Old (2016-2021) & (K Units)

Figure 17. Global Mebendazole Sales Market Share by Application (2016-2021)

Figure 18. Global Mebendazole Revenue Market Share by Application in 2020

Figure 19. Mebendazole Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Mebendazole Revenue Market Share by Company in 2020

Figure 21. Global Mebendazole Sales Market Share by Regions (2016-2021)

Figure 22. Global Mebendazole Revenue Market Share by Region in 2020

Figure 23. Americas Mebendazole Sales 2016-2021 (K Units)

Figure 24. Americas Mebendazole Revenue 2016-2021 ($ Millions)

Figure 25. APAC Mebendazole Sales 2016-2021 (K Units)

Figure 26. APAC Mebendazole Revenue 2016-2021 ($ Millions)

Figure 27. Europe Mebendazole Sales 2016-2021 (K Units)

Figure 28. Europe Mebendazole Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Mebendazole Sales 2016-2021 (K Units)

Figure 30. Middle East & Africa Mebendazole Revenue 2016-2021 ($ Millions)

Figure 31. Americas Mebendazole Sales Market Share by Country in 2020

Figure 32. Americas Mebendazole Revenue Market Share by Country in 2020

Figure 33. Americas Mebendazole Sales Market Share by Type in 2020

Figure 34. Americas Mebendazole Sales Market Share by Application in 2020

Figure 35. United States Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Mebendazole Sales Market Share by Region in 2020

Figure 40. APAC Mebendazole Revenue Market Share by Regions in 2020

Figure 41. APAC Mebendazole Sales Market Share by Type in 2020

Figure 42. APAC Mebendazole Sales Market Share by Application in 2020

Figure 43. China Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Mebendazole Sales Market Share by Country in 2020

Figure 50. Europe Mebendazole Revenue Market Share by Country in 2020

Figure 51. Europe Mebendazole Sales Market Share by Type in 2020

Figure 52. Europe Mebendazole Sales Market Share by Application in 2020

Figure 53. Germany Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Mebendazole Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Mebendazole Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Mebendazole Sales Market Share by Type in 2020

Figure 61. Middle East & Africa Mebendazole Sales Market Share by Application in 2020

Figure 62. Egypt Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Mebendazole Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

Please fill the form below, to recieve the report sample


+1